Verve Therapeutics is a clinical-stage company developing a new class of genetic medicines for cardiovascular disease with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The company’s lead programs – VERVE-102, VERVE-201, and VERVE-301 – target t...
Use this information to figure out if this company is an ideal customer for you.
978.501.3026
201 Brookline Avenue
Boston, 02215
501 - 1,000 Employees
$50M - $100M
linkedin.com/company/verve-therapeutics-inc
Verve Therapeutics's CEO is Sekar Kathiresan
Verve Therapeutics's CFO is Allison Dorval
Verve Therapeutics's HQ is located at 201 Brookline Avenue, Boston
Verve Therapeutics's phone number is 978.501.3026
Verve Therapeutics's official website is vervetx.com
Verve Therapeutics's revenue is $50M - $100M
Verve Therapeutics has 501 - 1,000 employees
Verve Therapeutics is in the industry of: Biotechnology
